CLINICAL TRIALS PROFILE FOR ADHANSIA XR
✉ Email this page to a colleague
All Clinical Trials for ADHANSIA XR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04507204 ↗ | Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) | Recruiting | Purdue Pharma LP | Phase 4 | 2020-07-30 | The purpose of this study is to investigate the treatment effectiveness of Adhansia XR at month-2 after initiation, and the effectiveness of Adhansia XR overall and when compared with the active comparator group (Concerta) over time. |
NCT04987762 ↗ | Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children | Recruiting | Purdue Pharma LP | Phase 4 | 2021-08-03 | The purpose of this study is to assess the long-term safety of Adhansia XR in children and to characterize the pharmacokinetics (PK) in 4 to 5 year-olds. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ADHANSIA XR
Condition Name
Clinical Trial Locations for ADHANSIA XR
Trials by Country
Clinical Trial Progress for ADHANSIA XR
Clinical Trial Phase
Clinical Trial Sponsors for ADHANSIA XR
Sponsor Name